Literature DB >> 16263253

Secreted protein acidic and rich in cysteine (SPARC/osteonectin/BM-40) binds to fibrinogen fragments D and E, but not to native fibrinogen.

Hua Wang1, Gail Workman, Shengfu Chen, Thomas H Barker, Buddy D Ratner, E Helene Sage, Shaoyi Jiang.   

Abstract

Secreted protein acidic and rich in cysteine (SPARC/osteonectin/BM-40) is a matricellular protein that functions in wound healing. Fibrinogen is a plasma protein involved in many aspects of wound healing, such as inflammation, fibrosis and thrombosis. In this study, the binding of SPARC to both native and plasmin-cleaved fibrinogen under physiological conditions was examined by the use of a surface plasmon resonance (SPR) biosensor. We show that SPARC binds to plasmin-cleaved fibrinogen, but not to native fibrinogen. SPARC binds to both fibrinogen fragments D and E fg D and fg E with similar dissociation constants (8.67 x 10(-8) M for Fg D and 1.61 x 10(-7) M for Fg E). Results from endothelial cell proliferation assays show that the binding of SPARC to Fg E suppressed the inhibition of proliferation by SPARC, whereas the binding of SPARC to Fg D did not influence the activity of SPARC on the cell cycle. The interaction of SPARC with fibrinogen fragments D and E, which are produced as a result of proteolytic activation of fibrinolysis, reveals potential storage sites in provisional extracellular matrix for SPARC during the wound healing process and indicates a regulatory role of SPARC in fibrinolysis and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263253     DOI: 10.1016/j.matbio.2005.09.004

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  7 in total

1.  Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens.

Authors:  Camilla Giudici; Nicolas Raynal; Hanna Wiedemann; Wayne A Cabral; Joan C Marini; Rupert Timpl; Hans Peter Bächinger; Richard W Farndale; Takako Sasaki; Ruggero Tenni
Journal:  J Biol Chem       Date:  2008-05-16       Impact factor: 5.157

Review 2.  Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level.

Authors:  Ashley C Brown; Thomas H Barker
Journal:  Acta Biomater       Date:  2013-09-19       Impact factor: 8.947

Review 3.  Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification.

Authors:  Shuyu Wen; Ying Zhou; Wai Yen Yim; Shijie Wang; Li Xu; Jiawei Shi; Weihua Qiao; Nianguo Dong
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

4.  Differences in gene expression profiles from asbestos-treated SPARC-null and wild-type mouse lungs.

Authors:  Mark A Pershouse; Aubrey M Smartt; Corbin Schwanke; Elizabeth A Putnam
Journal:  Genomics       Date:  2009-05-13       Impact factor: 5.736

5.  Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone.

Authors:  Alexandre Chlenski; Lisa J Guerrero; Helen R Salwen; Qiwei Yang; Yufeng Tian; Andres Morales La Madrid; Salida Mirzoeva; Patrice G Bouyer; David Xu; Matthew Walker; Susan L Cohn
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

6.  A peptide of SPARC interferes with the interaction between caspase8 and Bcl2 to resensitize chemoresistant tumors and enhance their regression in vivo.

Authors:  Mahbuba Rahman; Annie P K Chan; Michelle Tang; Isabella T Tai
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

Review 7.  Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases.

Authors:  Lucia Recinella; Giustino Orlando; Claudio Ferrante; Annalisa Chiavaroli; Luigi Brunetti; Sheila Leone
Journal:  Front Physiol       Date:  2020-10-30       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.